Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Why Vivos Therapeutics Shares Are Nosediving

Vivos Therapeutics Inc (NASDAQ: VVOS) shares are trading lower by 9.57% to $1.70 Thursday morning after the company priced an $8 million private placement at $1.20 per unit.
byHenry Khederian
January 5, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Vivos Therapeutics Inc (NASDAQ:VVOS) shares are trading lower by 9.57% to $1.70 Thursday morning after the company priced an $8 million private placement at $1.20 per unit.

Vivos Therapeutics says, after the placement agent fees and estimated offering expenses payable by the company, Vivos expects to receive net proceeds of approximately $7.5 million.

The offering is expected to close on January 9, subject to customary closing conditions.

See Also: What’s Going On With Apple Stock Today?

According to data from Benzinga Pro, VVOS has a 52-week high of $3.69 and a 52-week low of $0.34.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

$1.5M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying

By Lisa Levin
May 16, 7:49 AM
The Dow Jones closed higher on Monday after recording losses last week. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

CIA

Read More

Home Run To Homewrecker – Analyst Cautious On Homebuilders, Downgrades Key Players

By Lekha Gupta
January 22, 2:29 PM
Seaport analyst Kenneth Zener adjusts his stance on homebuilding stocks, downgrading key players due to a cautious outlook for FY24. With recession concerns lingering, Zener anticipates potential challenges, emphasizing the risk of anticipated tailwinds transforming into headwinds. Builder margins are expected to stabilize, influenced by diminishing past incentives, counteracted by rising input costs.

DHI